Testosterone and glucose metabolism in men: Current concepts and controversies

Journal of Endocrinology

Volumn 220, Issue 3, 2014, Pages

  Grossmann, Mathis ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Diabetes; Glucose metabolism; Insulin resistance; Obesity; Testosterone

Indexed keywords

DIABETES; GLUCOSE METABOLISM; INSULIN RESISTANCE; OBESITY; TESTOSTERONE;

GLUCOSE; HUMANS; MALE; METABOLIC DISEASES; OBESITY; TESTOSTERONE;

EID: 84894324493     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0393     Document Type: Review

References (121)

1. Aarts E, van Wageningen B, Loves S, Janssen I, Berends F, Sweep F & de Boer H 2013 Gonadal status and outcome of bariatric surgery in obese men. Clinical Endocrinology [in press]. (doi:10.1111/cen.12366)
2. Allan CA 2013 Sex steroids and glucose metabolism. Asian Journal of Andrology [in press].
3. Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI 2008 Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. Journal of Clinical Endocrinology and Metabolism 93 139-146. (doi:10.1210/jc.2007-1291)
4. Allan CA, Strauss BJG, Forbes EA & McLachlan RI 2010 Testosterone therapy improves body composition and metabolic parameters in obese aging men: results of a placebo-controlled randomized controlled trial. 92nd Annual Meeting of the Endocrine Society, San Diego P2-455.
5. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA 2011 Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 96 3007-3019. (doi:10.1210/jc.2011-1137)
6. Basaria S, Coviello AD, Travison TG, StorerTW, FarwellWR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A et al. 2010 Adverse events associated with testosterone administration. New England Journal of Medicine 363 109-122. (doi:10.1056/NEJMoa1000485)
7. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C et al. 2007 Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care 30 1972-1978. (doi:10.2337/dc07-0359)
8. Bhasin S,Woodhouse L, Casaburi R, Singh AB,Mac RP, Lee M, Yarasheski KE, Sinha-Hikim I, Dzekov C, Dzekov J et al. 2005 Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. Journal of Clinical Endocrinology and Metabolism 90 678-688. (doi:10.1210/jc.2004-1184)
9. Bhasin S, Calof OM, Storer TW, Lee ML, Mazer NA, Jasuja R, Montori VM, Gao W, Dalton JT 2006 Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nature Clinical Practice. Endocrinology, Metabolism 2 146-159. (doi:10.1038/ncpendmet0120)
10. Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B,Umbleja T&ShikumaCM 2007 Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virusinfected men with abdominal obesity. Journal of Clinical Endocrinology and Metabolism 92 1049-1057. (doi:10.1210/jc.2006-2060)
11. Bhasin S, CunninghamGR,Hayes FJ,MatsumotoAM, Snyder PJ, Swerdloff RS, Montori VM 2010 Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 95 2536-2559. (doi:10.1210/jc.2009-2354)
12. Bhasin S, Jasjua GK, Pencina M, D'Agostino R Sr, Coviello AD, Vasan RS & Travison TG 2011a Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study. Diabetes Care 34 2464-2470. (doi:10.2337/dc11-0888)
13. Bhasin S, PencinaM, Jasuja GK, Travison TG, Coviello A, Orwoll E,Wang PY, Nielson C, Wu F, Tajar A et al. 2011b Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. Journal of Clinical Endocrinology and Metabolism 96 2430-2439. (doi:10.1210/jc.2010-3012)
14. Biswas M, Hampton D, Newcombe RG, Rees DA 2012 Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life. Clinical Endocrinology 76 665-673. (doi:10.1111/j.1365-2265.2011. 04196.x)
15. Bonnet F, Velayoudom Cephise FL, Gautier A,Dubois S,Massart C, Camara A, Larifla L, Balkau B & Ducluzeau PH 2013 Role of sex steroids, intrahepatic fat and liver enzymes in the association between SHBG and metabolic features. Clinical Endocrinology 79 517-522. (doi:10.1111/cen.12089)
16. Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S 2005 Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebocontrolled trials. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60 1451-1457. (doi:10.1093/gerona/60.11.1451)
17. Camacho EM, Huhtaniemi IT, O'Neill TW, Finn JD, Pye SR, Lee DM, Tajar A, Bartfai G, Boonen S, Casanueva FF et al. 2013 Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. European Journal of Endocrinology 168 445-455. (doi:10.1530/EJE-12-0890)
18. Cameron DF, Rountree J, Schultz RE, Repetta D, Murray FT 1990 Sustained hyperglycemia results in testicular dysfunction and reduced fertility potential in BBWOR diabetic rats. American Journal of Physiology 259 E881-E889.
19. Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M & Rosano GM 2009 Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. Journal of the American College of Cardiology 54 919-927. (doi:10.1016/j.jacc.2009.04.078)
20. Caronia LM, Dwyer AA, Hayden D, Amati F, Pitteloud N, Hayes FJ 2013 Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism. Clinical Endocrinology 78 291-296. (doi:10.1111/j.1365-2265.2012.04486.x)
21. Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, Forti G, Mannucci E &MaggiM2010 Type 2 diabetes mellitus and testosterone: a meta-analysis study. International Journal of Andrology 34 528-540. (doi:10.1111/j.1365-2605.2010.01117.x)
22. Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E, Maggi M 2011 Testosterone and metabolic syndrome: a meta-analysis study. Journal of Sexual Medicine 8 272-283. (doi:10.1111/j.1743-6109.2010.01991.x)
23. Corona G, Rastrelli G & Maggi M 2013a Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best Practice & Research. Clinical Endocrinology & Metabolism 27 557-579. (doi:10.1016/j.beem.2013.05.002)
24. Corona G, Rastrelli G, Monami M, Saad F, Luconi M, Lucchese M, Facchiano E, Sforza A, Forti G, Mannucci E et al. 2013b Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. European Journal of Endocrinology 168 829-843. (doi:10.1530/EJE-12-0955)
25. Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S 2008 Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. Journal of Clinical Endocrinology and Metabolism 93 914-919. (doi:10.1210/jc.2007-1692)
26. Cunningham GR & Toma SM 2011 Clinical review: why is androgen replacement inmales controversial? Journal of Clinical Endocrinology and Metabolism 96 38-52. (doi:10.1210/jc.2010-0266)
27. Dandona , Dhindsa S 2011 Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. Journal of Clinical Endocrinology and Metabolism 96 2643-2651. (doi:10.1210/jc.2010-2724)
28. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A & Dandona P 2004 Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 89 5462-5468. (doi:10.1210/jc.2004-0804)
29. Dhindsa S, Bhatia V, Dhindsa G, Chaudhuri A, Gollapudi GM, Dandona P 2007 The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients. Diabetes Care 30 1860-1861. (doi:10.2337/dc07-0337)
30. Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A & Dandona P 2010 Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care 33 1186-1192. (doi:10.2337/ dc09-1649)
31. Dhindsa S, Furlanetto R, Vora M, Ghanim H, Chaudhuri A, Dandona P 2011 Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes. Diabetes Care 34 1854-1859. (doi:10.2337/dc11-0208)
32. Ding EL, Song Y, Malik VS & Liu S 2006 Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and metaanalysis. Journal of the American Medical Association 295 1288-1299. (doi:10.1001/jama.295.11.1288)
33. DingEL, SongY,MansonJE,HunterDJ, LeeCC,Rifai N,BuringJE,GazianoJM, Liu S 2009 Sex hormone-binding globulin and risk of type 2 diabetes in women and men. New England Journal of Medicine 361 1152-1163. (doi:10.1056/NEJMoa0804381)
34. Dwyer AA, Caronia LM, Lee H, Nathan DM & Hayes FJ 2012 Lifestyle modification can reverse hypogonadism in men with impaired glucose tolerance in the diabetes prevention program. Endocrine Reviews 33 OR28.3.
35. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT 2008 Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. Journal of the American Medical Association 299 39-52. (doi:10.1001/jama. 2007.51)
36. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S et al. 2002 Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation 110 1093-1103.
37. Fernandez-BalsellsMM, MuradMH, LaneM, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB,Gallegos-Orozco JF,WangATet al. 2010 Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 95 2560-2575. (doi:10.1210/jc.2009-2575)
38. Fernando SM, Rao P, Niel L, Chatterjee D, Stagljar M, Monks DA 2010 Myocyte androgen receptors increase metabolic rate and improve bodycomposition by reducing fat mass. Endocrinology 151 3125-3132. (doi:10.1210/en.2010-0018)
39. Finkelstein JS, Lee H, Burnett-Bowie SAM, Pallais JC, Yu EW, Borges LF, Jones BF, Barry CV, Wulczyn KE, Thomas BJ et al. 2013 Gonadal steroids and body composition, strength, and sexual function in men. New England Journal of Medicine 369 1011-1022. (doi:10.1056/ NEJMoa1206168)
40. George JT, Veldhuis JD, Tena-Sempere M, Millar RP, Anderson RA 2013 Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism. Clinical Endocrinology 79 100-104. (doi:10.1111/cen.12103)
41. Gopal RA, Bothra N, Acharya SV, Ganesh HK, Bandgar TR, Menon PS & Shah NS 2010 Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus. Endocrine Practice 16 570-576. (doi:10.4158/EP09355.OR)
42. Grossmann M 2011 Low testosterone in men with type 2 diabetes: significance and treatment. Journal of Clinical Endocrinology and Metabolism 96 2341-2353. (doi:10.1210/jc.2011-0118)
43. Grossmann M, Wittert G 2012 Androgens, diabetes and prostate cancer. Endocrine-Related Cancer 19 F47-F62. (doi:10.1530/ERC-12-0067)
44. Grossmann M & Zajac JD 2011a Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated? Clinical Endocrinology 74 289-293. (doi:10.1111/j.1365-2265. 2010.03939.x)
45. Grossmann M, Zajac JD 2011b Management of side effects of androgen deprivation therapy. Endocrinology and Metabolism Clinics of North America 40 655-671. (doi:10.1016/j.ecl.2011.05.004)
46. Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD & Jerums G 2008 Low testosterone levels are common and associated with insulin resistance in men with diabetes. Journal of Clinical Endocrinology and Metabolism 93 1834-1840. (doi:10.1210/jc. 2007-2177)
47. GrossmannM, Panagiotopolous S, Sharpe K, MacIsaac RJ, Clarke S, Zajac JD, Jerums G, Thomas MC 2009 Low testosterone and anaemia in men with type 2 diabetes. Clinical Endocrinology 70 547-553. (doi:10.1111/j. 1365-2265.2008.03357.x)
48. Grossmann M, Gianatti EJ & Zajac JD 2010 Testosterone and type 2 diabetes. Current Opinion in Endocrinology, Diabetes, and Obesity 17 247-256. (doi:10.1097/MED.0b013e32833919cf)
49. GrossmannM,HoermannR,Gani L,Chan I,CheungA,GowPJ, LiA, Zajac JD, Angus P 2012 Low testosterone levels as an independent predictor of mortality in men with chronic liver disease. Clinical Endocrinology 77 323-328. (doi:10.1111/j.1365-2265.2012.04347.x)
50. Groth KA, Skakkebaek A, Host C, Gravholt CH & Bojesen A 2013 Clinical review: Klinefelter syndrome - a clinical update. Journal of Clinical Endocrinology and Metabolism 98 20-30. (doi:10.1210/jc.2012-2382)
51. Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P, the BLAST Study Group 2013 Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study. Journal of Sexual Medicine [in press]. (doi:10.1111/jsm.12404)
52. Hamilton EJ, Gianatti E, Strauss BJ, Wentworth J, Lim-Joon D, Bolton D, Zajac JD & Grossmann M 2011 Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy. Clinical Endocrinology 74 377-383. (doi:10.1111/ j.1365-2265.2010.03942.x)
53. Hanchang W, Semprasert N, Limjindaporn T, Yenchitsomanus PT, Kooptiwut S 2013 Testosterone protects against glucotoxicity induced apoptosis of pancreatic b-cells (INS-1) and male mouse pancreatic islets. Endocrinology 154 4058-4067. (doi:10.1210/en.2013-1351)
54. Haring R, Ittermann T, Volzke H, Krebs A, Zygmunt M, Felix SB, Grabe HJ, NauckM& Wallaschofski H 2010 Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania. Aging Male 13 247-257. (doi:10.3109/13685538.2010.487553)
55. Haring R, Teumer A, Volker U, Dorr M, Nauck M, Biffar R, Volzke H, Baumeister SE, Wallaschofski H 2013 Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic risk factors and mortality. Andrology 1 17-23. (doi:10.1111/j.2047-2927. 2012.00002.x)
56. HazlehurstJM,ArmstrongMJ, SherlockM,Rowe IA,O'ReillyMW, FranklynJA, Stewart PM & Tomlinson JW2013 A comparative quality assessment of evidence-based clinical guidelines in endocrinology. Clinical Endocrinology 78 183-190. (doi:10.1111/j.1365-2265.2012.04441.x)
57. Heufelder AE, Saad F, Bunck MC, Gooren L 2009 Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. Journal of Andrology 30 726-733. (doi:10.2164/jandrol.108.007005)
58. Hoyos CM, Killick R, Yee BJ, Grunstein RR & Liu PY 2012a Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial. Clinical Endocrinology 77 599-607. (doi:10.1111/j.1365-2265.2012. 04413.x)
59. Hoyos CM, Yee BJ, Phillips CL, Machan EA, Grunstein RR, Liu PY 2012b Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial. European Journal of Endocrinology 167 531-541. (doi:10.1530/EJE-12-0525)
60. Huang G, Bhasin S, Tang ER, Aakil A, Anderson SW, Jara H, Davda M, Travison TG & Basaria S 2013 Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 68 954-959. (doi:10.1093/gerona/gls259)
61. Huhtaniemi I 2013 Late-onset hypogonadism; current concepts and controversies of pathogenesis, diagnosis and treatment. Asian Journal of Andrology [in press].
62. Huhtaniemi IT, Tajar A, Lee DM, O'Neill TW, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS et al. 2012 Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. European Journal of Endocrinology 166 983-991. (doi:10.1530/EJE-11-1051)
63. Iranmanesh A, Lawson D, Veldhuis JD 2012 Glucose ingestion acutely lowers pulsatile LH and basal testosterone secretion in men. American Journal of Physiology. Endocrinology and Metabolism 302 E724-E730. (doi:10.1152/ajpendo.00520.2011)
64. Isidori AM, Giannetta E,Greco EA,GianfrilliD, Bonifacio V, Isidori A, Lenzi A & Fabbri A 2005 Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a metaanalysis. Clinical Endocrinology 63 280-293. (doi:10.1111/j.1365-2265. 2005.02339.x)
65. Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I,Morales AM, Volterrani M, Yellowlees A, Howell JD et al. 2011 Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study). Diabetes Care 34 828-847. (doi:10.2337/dc10-1233)
66. Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ, Saad F 2010 Effects of testosterone supplementation on markers of themetabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clinical Endocrinology 73 602-612. (doi:10.1111/j.1365-2265. 2010.03845.x)
67. Kapoor D, Goodwin E, Channer KS & Jones TH 2006 Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. European Journal of Endocrinology 154 899-906. (doi:10.1530/eje.1.02166)
68. Kapoor D, Aldred H, Clark S, Channer KS, Jones TH 2007 Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 30 911-917. (doi:10.2337/dc06-1426)
69. Kelly DM & Jones TH 2013 Testosterone: a metabolic hormone in health and disease. Journal of Endocrinology 217 R25-R45. (doi:10.1530/ JOE-12-0455)
70. Khoo J, Piantadosi C, Worthley S, Wittert GA 2010 Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men. International Journal of Obesity 34 1396-1403. (doi:10.1038/ ijo.2010.76)
71. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ & McKinlay JB 2006 Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Journal of Clinical Endocrinology and Metabolism 91 843-850. (doi:10.1210/jc.2005-1326)
72. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen JT 2005 The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. Journal of Clinical Endocrinology and Metabolism 90 712-719. (doi:10.1210/jc.2004-0970)
73. LeeNK, SowaH, Hinoi E, FerronM,Ahn JD,ConfavreuxC,Dacquin R,Mee PJ, McKee MD, Jung DY et al. 2007 Endocrine regulation of energy metabolism by the skeleton. Cell 130 456-469. (doi:10.1016/j.cell. 2007.05.047)
74. Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD et al. 2008 Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 47 1924-1935. (doi:10.1002/hep.22252)
75. Liu PY, Wishart SM, Celermajer DS, Jimenez M, Pierro ID, Conway AJ, Handelsman DJ 2003 Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomized, placebocontrolled clinical trial of recombinant human chorionic gonadotropin European Journal of Endocrinology 148 55-66. (doi:10.1530/eje.0.1480055)
76. Marin P, Oden B & Bjorntorp P 1995 Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. Journal of Clinical Endocrinology and Metabolism 80 239-243. (doi:10.1210/jc.80.1.239)
77. Matsumoto AM 2013 Testosterone administration in older men. Endocrinology and Metabolism Clinics of North America 42 271-286. (doi:10.1016/j.ecl.2013.02.011)
78. McInnes KJ, Smith LB, Hunger NI, Saunders PT, Andrew R, Walker BR 2012 Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis. Diabetes 61 1072-1081. (doi:10.2337/db11-1136)
79. McLachlan RI 2010 Certainly more guidelines than rules. Journal of Clinical Endocrinology and Metabolism 95 2610-2613. (doi:10.1210/jc.2010-0838)
80. Monroe KA, Dobs AS 2013 The effects of androgens on lipids. Current Opinion in Endocrinology, Diabetes, and Obesity 20 132-139. (doi:10.1097/MED.0b013e32835edb71)
81. Muraleedharan V, Marsh H, Kapoor D, Channer KS & Jones TH 2013 Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. European Journal of Endocrinology 169 725-733. (doi:10.1530/ EJE-13-0321)
82. Navarro VM, Kaiser UB 2013 Metabolic influences on neuroendocrine regulation of reproduction. Current Opinion in Endocrinology, Diabetes, and Obesity 20 335-341.
83. Ng Tang Fui M, Dupuis P & Grossmann M 2013a Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian Journal of Andrology [in press].
84. Ng Tang Fui M, Hoermann R, Cheung AS, Gianatti E, Zajac JD, Grossmann M 2013b Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status. Andrology 1 906-912. (doi:10.1111/j.2047-2927.2013.00124.x)
85. OuryF, Sumara G,Sumara O,FerronM,ChangH, SmithCE,HermoL,Suarez S, Roth BL, Ducy P et al. 2011 Endocrine regulation of male fertility by the skeleton. Cell 144 769-809. (doi:10.1016/j.cell.2011.02.004)
86. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, BremnerWJ, Tenover JL 2005 Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. Journal of Clinical Endocrinology and Metabolism 90 1502-1510. (doi:10.1210/jc.2004-1933)
87. PitteloudN,MoothaVK,DwyerAA, HardinM,LeeH, ErikssonKF, TripathyD, Yialamas M, Groop L, Elahi D et al. 2005 Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28 1636-1642. (doi:10.2337/diacare.28.7.1636)
88. Rabiee A, Dwyer AA, Caronia LM, Hayes FJ, Yialamas MA, Andersen DK, Thomas B, Torriani M, Elahi D 2010 Impact of acute biochemical castration on insulin sensitivity in healthy adult men. Endocrine Research 35 71-84. (doi:10.3109/07435801003705601)
89. Rana K, Fam BC, Clarke MV, Pang TP, Zajac JD & MacLean HE 2011 Increased adiposity in DNA binding-dependent androgen receptor knockout male mice associated with decreased voluntary activity and not insulin resistance. American Journal of Physiology. Endocrinology and Metabolism 301 E767-E778. (doi:10.1152/ajpendo.00584.2010)
90. Rao PM, Kelly DM, Jones TH 2013 Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nature Reviews. Endocrinology 9 479-493. (doi:10.1038/nrendo.2013.122)
91. Rastrelli G, Corona G, Vignozzi L, Maseroli E, Silverii A, Monami M, Mannucci E, Forti G & Maggi M 2013 Serum PSA as a predictor of testosterone deficiency. Journal of Sexual Medicine 10 2518-2528.
92. Rubinow KB, Snyder CN, Amory JK, Hoofnagle AN, Page ST 2012 Acute testosterone deprivation reduces insulin sensitivity in men. Clinical Endocrinology 76 281-288. (doi:10.1111/j.1365-2265.2011.04189.x)
93. Santosa S, Khosla S, McCready LK & JensenMD 2010 Effects of estrogen and testosterone on resting energy expenditure in older men. Obesity 18 2392-2394. (doi:10.1038/oby.2010.98)
94. Sartorius G, Spasevska S, Idan A, Turner L, Forbes E, Zamojska A, Allan CA, Ly LP, Conway AJ, McLachlan RI et al. 2012 Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clinical Endocrinology 77 755-763. (doi:10.1111/j.1365-2265.2012.04432.x)
95. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM 2012 Testosterone treatment and mortality in men with low testosterone levels. Journal of Clinical Endocrinology and Metabolism 97 2050-2058. (doi:10.1210/jc.2011-2591)
96. Singh AB, Hsia S, Alaupovic P, Sinha-Hikim I, Woodhouse L, Buchanan TA, Shen R, Bross R, Berman N & Bhasin S 2002 The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. Journal of Clinical Endocrinology and Metabolism 87 136-143. (doi:10.1210/jc.87.1.136)
97. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S 2003 Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144 5081-5088. (doi:10.1210/en.2003-0741)
98. Smith MR 2004 Changes in fat and lean body mass during androgendeprivation therapy for prostate cancer. Urology 63 742-745. (doi:10.1016/j.urology.2003.10.063)
99. Smith MR, Lee H, Nathan DM 2006 Insulin sensitivity during combined androgen blockade for prostate cancer. Journal of Clinical Endocrinology and Metabolism 91 1305-1308. (doi:10.1210/jc.2005-2507)
100. Spitzer M, Huang G, Basaria S, Travison TG & Bhasin S 2013 Risks and benefits of testosterone therapy in older men. Nature Reviews. Endocrinology 9 414-424. (doi:10.1038/nrendo.2013.73)
101. Srinivas-Shankar U, Roberts SA, Connolly MJ, O'Connell MD, Adams JE, Oldham JA, Wu FC 2010 Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 95 639-650. (doi:10.1210/jc.2009-1251)
102. Svartberg J, Agledahl I, Figenschau Y, Sildnes T,Waterloo K & Jorde R 2008 Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. International Journal of Impotence Research 20 378-387. (doi:10.1038/ijir.2008.19)
103. Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A et al. 2010 Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. Journal of Clinical Endocrinology and Metabolism 95 1810-1818. (doi:10.1210/jc.2009-1796)
104. Tajar A, Huhtaniemi IT, O'Neill TW, Finn JD, Pye SR, Lee DM, Bartfai G, Boonen S, Casanueva FF, Forti G et al. 2012 Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). Journal of Clinical Endocrinology and Metabolism 97 1508-1516. (doi:10.1210/jc.2011-2513)
105. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB 2007 The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. Journal of Clinical Endocrinology and Metabolism 92 549-555. (doi:10.1210/jc.2006-1859)
106. Travison TG, Shackelton R, Araujo AB, Hall SA, Williams RE, Clark RV, O'Donnell AB & McKinlay JB 2008 The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission. Journal of the American Geriatrics Society 56 831-839. (doi:10.1111/j.1532-5415.2008.01679.x)
107. Vigen R, O'Donnell CI, Baron AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A,Woning G,Wierman ME, Plomondon ME et al. 2013 Associationof testosterone therapy withmortality,myocardial infarction, and stroke inmen with low testosterone levels. Journal of the American Medical Association 310 1829-1836. (doi:10.1001/jama.2013.280386)
108. Wallace IR, McKinley MC, Bell PM, Hunter SJ 2013 Sex hormone binding globulin and insulin resistance. Clinical Endocrinology 78 321-329. (doi:10.1111/cen.12086)
109. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A et al. 2009 Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Journal of Andrology 30 1-9. (doi:10.2164/jandrol.108.006486)
110. Wu FC 2012 Caveat emptor: does testosterone treatment reduce mortality in men?. Journal of Clinical Endocrinology and Metabolism 97 1884-1886. (doi:10.1210/jc.2012-1977)
111. WuFC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD,O'NeillTW, Bartfai G, Casanueva FF, Forti G et al. 2010 Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicine 363 123-135. (doi:10.1056/NEJMoa0911101)
112. Xu XF, De Pergola G, Bjorntorp P 1991 Testosterone increases lipolysis and the number of b-adrenoceptors in male rat adipocytes. Endocrinology 128 379-382. (doi:10.1210/endo-128-1-379)
113. Xu L, Freeman G, Cowling BJ, Schooling CM 2013 Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Medicine 11 108. (doi:10.1186/1741-7015-11-108)
114. Yeap BB 2011 Osteocalcin: an endocrine link between bone and glucose metabolism. Expert Review of Endocrinology & Metabolism 6 177-185. (doi:10.1586/eem.11.7)
115. Yeap BB, Alfonso H, Chubb SA, Handelsman DJ, Hankey GJ, Norman PE, Flicker L 2012a Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men. Journal of Clinical Endocrinology and Metabolism 97 4030-4039. (doi:10.1210/jc.2012-2265)
116. Yeap BB, Araujo AB&WittertGA 2012b Do lowtestosterone levels contribute to ill-health during male ageing?. Critical Reviews in Clinical Laboratory Sciences 49 168-182. (doi:10.3109/10408363.2012.725461)
117. Yialamas MA, Dwyer AA, Hanley E, Lee H, Pitteloud N, Hayes FJ 2007 Acute sex steroid withdrawal reduces insulin sensitivity in healthymen with idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 92 4254-4259. (doi:10.1210/jc. 2007-0454)
118. Yu IC, Lin HY, Liu NC, Sparks JD, Yeh S, Fang LY, Chen L & Chang C 2013 Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-kB-mediated PTP1B expression. Diabetes 62 411-423. (doi:10.2337/db12-0135)
119. Zitzmann M, Nieschlag E 2007 Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 92 3844-3853. (doi:10.1210/jc.2007-0620)
120. Zitzmann M, Faber S & Nieschlag E 2006 Association of specific symptoms and metabolic risks with serum testosterone in older men. Journal of Clinical Endocrinology and Metabolism 91 4335-4343. (doi:10.1210/ jc.2006-0401)
121. Zumoff B, Miller LK, Strain GW 2003 Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Metabolism 52 1126-1128. (doi:10.1016/S0026- 0495(03)00186-0)